About Omixon
Omixon is a company based in Budapest (Hungary) founded in 2009 was acquired by Werfen in November 2024.. Omixon offers products and services including NanoTYPE™, Holotype HLA™, HoloGRAFT ONE™, and HLA Twin™. Omixon operates in a competitive market with competitors including MedGenome, Foundation Medicine, Helix, Benchling and Personalis, among others.
- Headquarter Budapest, Hungary
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Omixon Biocomputing Ltd.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Omixon
Omixon offers a comprehensive portfolio of products and services, including NanoTYPE™, Holotype HLA™, HoloGRAFT ONE™, and HLA Twin™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Nanopore-based long-read sequencing for HLA genotyping applications.
NGS assay and software for HLA typing on Illumina sequencers.
Test for measuring donor-derived cell-free DNA in transplants.
Genotyping software for processing and analyzing HLA data.
Unlock access to complete
Funding Insights of Omixon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Omixon
Omixon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Werfen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global leader for In Vitro Diagnostic
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Omixon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Omixon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Omixon Comparisons
Competitors of Omixon
Omixon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MedGenome, Foundation Medicine, Helix, Benchling and Personalis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Genomic database for clinical research is provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Genetic testing products for health risks and traits are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Omixon
Frequently Asked Questions about Omixon
When was Omixon founded?
Omixon was founded in 2009.
Where is Omixon located?
Omixon is headquartered in Budapest, Hungary.
What does Omixon do?
Omixon was founded in 2009 in Budapest, Hungary, where operations center on commercializing innovations for targeted Next Generation Sequencing applications in the genomics sector. The Holotype HLA product is offered, integrating a targeted HLA assay with HLA Twin software for high-resolution HLA genotyping. An active grant-funded research program is maintained, and support is provided to scientists and clinicians for analyzing genomic regions such as HLA, KIR, and ABO.
Who are the top competitors of Omixon?
Omixon's top competitors include Foundation Medicine, Helix and MedGenome.
What products or services does Omixon offer?
Omixon offers NanoTYPE™, Holotype HLA™, HoloGRAFT ONE™, and HLA Twin™.
Who are Omixon's investors?
Omixon has 1 investor. Key investors include Werfen.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.